Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female Participants
Clinical trial NCT04978688 · COMPLETED
Trial details
- NCT number
- NCT04978688
- Sponsor
- Myovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-16
- Primary completion
- 2016-09-21
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.